Gonen, A.; Hansen, L. F.; Turner, W. W.; Montano, E. N.; Que, X.; Rafia, A.; Chou, M.-Y.; Wiesner, P.; Tsiantoulas, D.; Corr, M.; VanNieuwenhze, M. S.; Tsimikas, S.; Binder, C. J.; Witztum, J. L.; Hartvigsen, K., J. Lipid Res. 2014, 55, 2137-2155.
- Home
- Atheroprotective immunization with malondialdehyde modified LDL is hapten specific, dependent on advanced MDA-adducts: Implications for development of an atheroprotective vaccine
- The College of Arts & Sciences
- The VanNieuwenhze Group